1
Biemans, VBC, Sleutjes, Jasmijn, de Vries, Annemarie, Bodelier, AG, Dijkstra, A, Oldenburg, B, Löwenberg, M, van Bodegraven, AA, de Jong, AEE, de Boer, NK, Srivastava, N, West, RL, Römkens, TEH, Horjus Talabur Horje, CS, Jansen, J, van der Woude, C.J., Hoekstra, J, Weersma, RK, van Schaik, FDM, Hoentjen, F, Pierik, MJ
Veröffentlicht in: Biemans , VBC , Sleutjes , J , de Vries , A , Bodelier , AG , Dijkstra , A , Oldenburg , B , Löwenberg , M , van Bodegraven , AA , de Jong , AEE , de Boer , NK , Srivastava , N , West , RL , Römkens , TEH , Horjus Talabur Horje , CS , Jansen , J , van der Woude , C J , Hoekstra , J , Weersma , RK , van Schaik , FDM , Hoentjen , F & Pierik , MJ 2020 , ' Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ' , Alimentary Pharmacology and Therapeutics , vol. 51 , no. 9 , pp. 880-888 . https://doi.org/10.1111/apt.15689;
2020
Veröffentlicht in: Biemans , VBC , Sleutjes , J , de Vries , A , Bodelier , AG , Dijkstra , A , Oldenburg , B , Löwenberg , M , van Bodegraven , AA , de Jong , AEE , de Boer , NK , Srivastava , N , West , RL , Römkens , TEH , Horjus Talabur Horje , CS , Jansen , J , van der Woude , C J , Hoekstra , J , Weersma , RK , van Schaik , FDM , Hoentjen , F & Pierik , MJ 2020 , ' Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ' , Alimentary Pharmacology and Therapeutics , vol. 51 , no. 9 , pp. 880-888 . https://doi.org/10.1111/apt.15689;
2020
2
Biemans, Vince B.C., Sleutjes, Jasmijn A.M., de Vries, Annemarie C., Bodelier, Alexander G.L., Dijkstra, Gerard, Oldenburg, Bas, Löwenberg, Mark, van Bodegraven, Adriaan A., van der Meulen-de Jong, Andrea E., de Boer, Nanne K.H., Srivastava, Nidhi, West, Rachel L., Römkens, Tessa E.H., Horjus Talabur Horje, Carmen S., Jansen, Jeroen M., van der Woude, C. Janneke, Hoekstra, Jildou, Weersma, Rinse K., van Schaik, Fiona D.M., Hoentjen, Frank, Pierik, Marieke J.
Veröffentlicht in: Biemans , V B C , Sleutjes , J A M , de Vries , A C , Bodelier , A G L , Dijkstra , G , Oldenburg , B , Löwenberg , M , van Bodegraven , A A , van der Meulen-de Jong , A E , de Boer , N K H , Srivastava , N , West , R L , Römkens , T E H , Horjus Talabur Horje , C S , Jansen , J M , van der Woude , C J , Hoekstra , J , Weersma , R K , van Schaik , F D M , Hoentjen , F , Pierik , M J & the Dutch Initiative on Crohn and Colitis (ICC) 2020 , ' Tofacitinib for ulcerative colitis : results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ' , Alimentary Pharmacology and Therapeutics , vol. 51 , no. 9 , pp. 880-888 . https://doi.org/10.1111/apt.15689;
2020
Veröffentlicht in: Biemans , V B C , Sleutjes , J A M , de Vries , A C , Bodelier , A G L , Dijkstra , G , Oldenburg , B , Löwenberg , M , van Bodegraven , A A , van der Meulen-de Jong , A E , de Boer , N K H , Srivastava , N , West , R L , Römkens , T E H , Horjus Talabur Horje , C S , Jansen , J M , van der Woude , C J , Hoekstra , J , Weersma , R K , van Schaik , F D M , Hoentjen , F , Pierik , M J & the Dutch Initiative on Crohn and Colitis (ICC) 2020 , ' Tofacitinib for ulcerative colitis : results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ' , Alimentary Pharmacology and Therapeutics , vol. 51 , no. 9 , pp. 880-888 . https://doi.org/10.1111/apt.15689;
2020